No Data
No Data
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals(RXRX.US) Director Sells US$104.94K in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on May 28, 2024 at an average price of $9.1677 for a total value of $104.94K.Source: Announcement What i
How Is The Market Feeling About Recursion Pharmaceuticals?
Recursion Pharmaceuticals's (NYSE:RXRX) short percent of float has risen 4.63% since its last report. The company recently reported that it has 42.37 million shares sold short, which is 26.88% of all
Hedge Funds Are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature Genetics scientific
No Data